Premature graying of hair: Risk factors, co‐morbid conditions, pharmacotherapy and reversal—A systematic review and meta‐analysis

S Mahendiratta, P Sarma, H Kaur, S Kaur… - Dermatologic …, 2020 - Wiley Online Library
Premature graying of hair (PGH) being a very common entity for which pharmacotherapy
and reversibility are not properly addressed. Therefore, this systematic review was …
被引用次数：17 相关文章

Premature graying of hair: Risk factors, co-morbid conditions, pharmacotherapy and reversal-A systematic review and meta-analysis.

S Mahendiratta, P Sarma, H Kaur, S Kaur… - Dermatologic …, 2020 - europepmc.org
Premature graying of hair (PGH) being a very common entity for which pharmacotherapy
and reversibility are not properly addressed. Therefore, this systematic review was …

Premature graying of hair: Risk factors, co-morbid conditions, pharmacotherapy and reversal-A systematic review and meta-analysis

S Mahendiratta, P Sarma, H Kaur… - Dermatologic …, 2020 - pubmed.ncbi.nlm.nih.gov
Premature graying of hair (PGH) being a very common entity for which pharmacotherapy
and reversibility are not properly addressed. Therefore, this systematic review was …

Premature graying of hair: Risk factors, co‐morbid conditions, pharmacotherapy and reversal—A systematic review and meta‐analysis.

S Mahendiratta, P Sarma, H Kaur, S Kaur… - Dermatologic …, 2020 - search.ebscohost.com
Premature graying of hair (PGH) being a very common entity for which pharmacotherapy
and reversibility are not properly addressed. Therefore, this systematic review was …